Search results
What causes long COVID? Case builds for rogue antibodies
Nature· 2 days agoStudy finds that antibodies from people with the debilitating condition trigger similar symptoms in...
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat...
Digital Journal· 3 days agoFood & Drug Administration (“FDA”) for the evaluation of a proposed clinical study of Bucillamine, an oral thiol-based drug with anti-inflammatory and antiviral properties, as a potential < ...
Roche (RHHBY) NSCLC Drug Alecensa Gets EC Nod for Label Expansion
Zacks via Yahoo Finance· 4 days agoRoche's (RHHBY) Alecensa gets the European Commission's approval as the first and only targeted...
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 4 days agoAn experimental two-in-one vaccine triggered strong immune responses against both the flu and SARS-CoV-2, the virus behind COVID-19, in an advanced clinical ...
WHO and Switzerland strengthen partnership for global BioHub System
World Health Organization· 1 day agoThe Government of Switzerland and the World Health Organization (WHO) have extended their...
RedHill Biopharma (NASDAQ:RDHL) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 23 hours agoStockNews.com began coverage on shares of RedHill Biopharma (NASDAQ:RDHL – Free Report) in a research report sent to investors on Thursday. The firm issued a hold rating on the biotechnology ...
CureVac (NASDAQ:CVAC) Shares Down 4.8%
ETF DAILY NEWS· 6 days agoShares of CureVac (NASDAQ:CVAC – Get Free Report) traded down 4.8% during trading on Friday . The company traded as low as $4.67 and last traded at $4.75. 115,327 shares traded hands during ...
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral...
The News & Observer· 4 days agoA First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
...Accepts "Non-Traditional" Covid Vaccines May In Fact Be Treatments (and Hence Should Not Have...
Naked Capitalism· 4 days agoKey question for consequentialists: If "non-traditional" vaccines are in fact treatments as under...
NIH collaborates with diagnostics manufacturers on | Newswise
Newswise· 3 days agoTo date, nine medical device developers participating in the RADx® Tech Independent Test Assessment Program have received emergency use authorization for